CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677 | -71.1% | 24,832 | -76.4% | 0.01% | -68.4% |
| Q2 2023 | $2,339 | +91.4% | 105,110 | +86.3% | 0.02% | +90.0% |
| Q1 2023 | $1,222 | +44.4% | 56,409 | +35.4% | 0.01% | -16.7% |
| Q4 2022 | $846 | -99.8% | 41,654 | +116.8% | 0.01% | +100.0% |
| Q2 2022 | $457,000 | -76.9% | 19,210 | -78.1% | 0.01% | -76.0% |
| Q1 2022 | $1,976,000 | +29.6% | 87,754 | +13.9% | 0.02% | +56.2% |
| Q4 2021 | $1,525,000 | +263.1% | 77,027 | +379.8% | 0.02% | +300.0% |
| Q4 2020 | $420,000 | -44.7% | 16,053 | -63.2% | 0.00% | -73.3% |
| Q3 2020 | $759,000 | +69.0% | 43,590 | +17.4% | 0.02% | +87.5% |
| Q4 2019 | $449,000 | +43.9% | 37,139 | +68.3% | 0.01% | -27.3% |
| Q3 2019 | $312,000 | – | 22,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |